Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kami J Maddocks

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Haematologica|May 17, 2020
Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemiaNyla A Heerema, Natarajan Muthusamy, Qiuhong Zhao, et al.
British Journal of Haematology|December 2, 2017
A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factorKerry A Rogers, Ying Huang, Amy S Ruppert, et al.
Haematologica|August 30, 2023
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND studyJohannes Duell, Pau Abrisqueta, Marc Andre, et al.
Hematological Oncology|May 10, 2024
Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patientsKaitlin Annunzio, Subodh Bhatta, Walter Hanel, et al.
Leukemia|July 25, 2020
Second cancer incidence in CLL patients receiving BTK inhibitorsDavid A Bond, Ying Huang, James L Fisher, et al.
Oncotarget|April 24, 2016
Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemiaTimothy L Chen, Nikhil Gupta, Amy Lehman, et al.
Blood|March 31, 2010
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibitionErin Hertlein, Amy J Wagner, Jeffrey Jones, et al.
Blood|August 17, 2018
Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemiaKerry A Rogers, Ying Huang, Amy S Ruppert, et al.
Leukemia & Lymphoma|February 12, 2015
Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphomaFarrukh T Awan, Joseph M Flynn, Jeffrey A Jones, et al.
Cancer|March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survivalJonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Haematologica|May 17, 2020
Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemiaNyla A Heerema, Natarajan Muthusamy, Qiuhong Zhao, et al.
British Journal of Haematology|December 2, 2017
A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factorKerry A Rogers, Ying Huang, Amy S Ruppert, et al.
Haematologica|August 30, 2023
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND studyJohannes Duell, Pau Abrisqueta, Marc Andre, et al.
Hematological Oncology|May 10, 2024
Prognostic relevance of circulating lymphoma cells at diagnosis in newly diagnosed follicular lymphoma patientsKaitlin Annunzio, Subodh Bhatta, Walter Hanel, et al.
Leukemia|July 25, 2020
Second cancer incidence in CLL patients receiving BTK inhibitorsDavid A Bond, Ying Huang, James L Fisher, et al.
Oncotarget|April 24, 2016
Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemiaTimothy L Chen, Nikhil Gupta, Amy Lehman, et al.
Blood|March 31, 2010
17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibitionErin Hertlein, Amy J Wagner, Jeffrey Jones, et al.
Blood|August 17, 2018
Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemiaKerry A Rogers, Ying Huang, Amy S Ruppert, et al.
Leukemia & Lymphoma|February 12, 2015
Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphomaFarrukh T Awan, Joseph M Flynn, Jeffrey A Jones, et al.
Cancer|March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survivalJonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.
Pageof 5